Bioxytran BIXT Stock
Bioxytran Price Chart
Bioxytran BIXT Financial and Trading Overview
| Bioxytran stock price | 0.15 USD |
| Previous Close | 0.22 USD |
| Open | 0.23 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.23 - 0.23 USD |
| 52 Week Range | 0.19 - 1.25 USD |
| Volume | 22.07K USD |
| Avg. Volume | 56.62K USD |
| Market Cap | 30.04M USD |
| Beta (5Y Monthly) | 0.03543 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.71 USD |
BIXT Valuation Measures
| Enterprise Value | 30.45M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -14.742 |
Trading Information
Bioxytran Stock Price History
| Beta (5Y Monthly) | 0.03543 |
| 52-Week Change | -43.98% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.25 USD |
| 52 Week Low | 0.19 USD |
| 50-Day Moving Average | 0.4 USD |
| 200-Day Moving Average | 0.48 USD |
BIXT Share Statistics
| Avg. Volume (3 month) | 56.62K USD |
| Avg. Daily Volume (10-Days) | 64.77K USD |
| Shares Outstanding | 130.6M |
| Float | 29.08M |
| Short Ratio | N/A |
| % Held by Insiders | 67.37% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -248.26% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -2065248 USD |
| Net Income Avi to Common (ttm) | -2336745 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 153.8K USD |
| Total Cash Per Share (mrq) | 0.001 USD |
| Total Debt (mrq) | 2.17M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.036 |
| Book Value Per Share (mrq) | -0.028 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1301149 USD |
| Levered Free Cash Flow (ttm) | -396632 USD |
Profile of Bioxytran
| Country | United States |
| State | MA |
| City | Newton |
| Address | 233 Needham Street |
| ZIP | 02464 |
| Phone | 617 454 1199 |
| Website | https://www.bioxytraninc.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLectin-Rx, a polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin for treatment of mild to moderate cases of Covid-19. The company was incorporated in 2008 and is headquartered in Newton, Massachusetts.
Q&A For Bioxytran Stock
What is a current BIXT stock price?
Bioxytran BIXT stock price today per share is 0.15 USD.
How to purchase Bioxytran stock?
You can buy BIXT shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bioxytran?
The stock symbol or ticker of Bioxytran is BIXT.
Which industry does the Bioxytran company belong to?
The Bioxytran industry is Biotechnology.
How many shares does Bioxytran have in circulation?
The max supply of Bioxytran shares is 88.13M.
What is Bioxytran Price to Earnings Ratio (PE Ratio)?
Bioxytran PE Ratio is now.
What was Bioxytran earnings per share over the trailing 12 months (TTM)?
Bioxytran EPS is -0.01 USD over the trailing 12 months.
Which sector does the Bioxytran company belong to?
The Bioxytran sector is Healthcare.